520 related articles for article (PubMed ID: 8038948)
21. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
[TBL] [Abstract][Full Text] [Related]
22. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
Ottevanger EA
Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
[TBL] [Abstract][Full Text] [Related]
23. Treatment options in the management of adolescent depression.
Weller EB; Weller RA
J Affect Disord; 2000 Dec; 61 Suppl 1():23-8. PubMed ID: 11155965
[TBL] [Abstract][Full Text] [Related]
24. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
Barak Y; Kimhi R; Weizman R
Int Clin Psychopharmacol; 2000 Jan; 15(1):53-6. PubMed ID: 10836288
[TBL] [Abstract][Full Text] [Related]
25. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
27. Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients.
Miller FT; Freilicher J
J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):173-6. PubMed ID: 7576042
[TBL] [Abstract][Full Text] [Related]
28. [Multiple sclerosis and major depression resistant to treatment. Case of a patient with antidepressive therapy-induced mood disorder, associated with manic features].
Pariante CM; Orrù MG; Carpiniello B; Rudas N
Clin Ter; 1995; 146(6-7):449-52. PubMed ID: 7586996
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-induced manic switches.
Furukawa T
Am J Psychiatry; 1996 Oct; 153(10):1370. PubMed ID: 8831460
[No Abstract] [Full Text] [Related]
30. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Preskorn S
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
[TBL] [Abstract][Full Text] [Related]
31. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
32. Risk of mania with antidepressants.
Baldessarini RJ; Faedda GL; Hennen J
Arch Pediatr Adolesc Med; 2005 Mar; 159(3):298; author reply 298-9. PubMed ID: 15753278
[No Abstract] [Full Text] [Related]
33. The behavioural toxicity of the selective serotonin reuptake inhibitors.
Hindmarch I
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():13-7. PubMed ID: 7622818
[TBL] [Abstract][Full Text] [Related]
34. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
Dunner DL; D'Souza DN; Kajdasz DK; Detke MJ; Russell JM
J Affect Disord; 2005 Jul; 87(1):115-9. PubMed ID: 15967235
[TBL] [Abstract][Full Text] [Related]
35. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Sussman N; Ginsberg DL; Bikoff J
J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
[TBL] [Abstract][Full Text] [Related]
36. Management of patients with depression associated with anxiety symptoms.
Nutt D
J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
[TBL] [Abstract][Full Text] [Related]
37. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
39. Weight gain and antidepressants.
Fava M
J Clin Psychiatry; 2000; 61 Suppl 11():37-41. PubMed ID: 10926053
[TBL] [Abstract][Full Text] [Related]
40. Depressive subtypes and efficacy of antidepressive pharmacotherapy.
Ayuso-Gutiérrez JL
World J Biol Psychiatry; 2005; 6 Suppl 2():31-7. PubMed ID: 16166021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
